{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:12:36Z","timestamp":1791202356882,"version":"4.2.0"},"reference-count":42,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2011,1,11]],"date-time":"2011-01-11T00:00:00Z","timestamp":1294704000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Viral Hepatitis"],"published-print":{"date-parts":[[2011,7]]},"abstract":"<jats:p><jats:bold>Summary.\u2002<\/jats:bold> The impact of antiretroviral drug exposure and associated lipodystrophy and\/or insulin resistance (IR) on advanced liver fibrosis in HIV\/HCV\u2010coinfected patients is not fully documented. We determined the prevalence of advanced liver fibrosis (defined by hepatic stiffness \u22659.5\u2003kPa) and associated factors, focusing on the impact of highly active antiretroviral therapy and its major adverse effects (lipodystrophy and IR), in 671 HIV\/HCV\u2010coinfected patients included in the ANRS CO13 HEPAVIH cohort. One hundred ninety patients (28.3%) had advanced liver fibrosis. In univariate analysis, advanced liver fibrosis was significantly associated with male sex, higher body mass index, HCV infection through intravenous drug use, a lower absolute CD4 cell count, a longer history of antiretroviral treatment, longer durations of protease inhibitors, non\u2010nucleoside reverse transcriptase inhibitors and NRTI exposure, lipodystrophy, diabetes, and a high homeostasis model assessment method (HOMA) value. The only antiretroviral drugs associated with advanced liver fibrosis were efavirenz, stavudine and didanosine. In multivariate analysis, male sex (OR 2.0, 95% CI 1.1\u20133.5; <jats:italic>P<\/jats:italic>\u2003=\u20030.018), HCV infection through intravenous drug use (OR 2.0, 95% CI 1.1\u20133.6; <jats:italic>P<\/jats:italic>\u2003=\u20030.018), lipodystrophy (OR 2.0, 95% CI 1.2\u20133.3; <jats:italic>P<\/jats:italic>\u2003= 0.01), median didanosine exposure longer than 5\u2003months (OR 1.7, 95% CI 1.0\u20132.8; <jats:italic>P<\/jats:italic>\u2003=\u20030.04) and a high HOMA value (OR 1.1, 95% CI 1.0\u20131.2; <jats:italic>P<\/jats:italic>\u2003=\u20030.005) remained significantly associated with advanced liver fibrosis. Mitochondrial toxicity and IR thus appear to play a key role in liver damage associated with HIV\/HCV\u2010coinfection, and this should be taken into account when selecting and optimizing antiretroviral therapy. Antiretroviral drugs with strong mitochondrial toxicity (e.g. didanosine) or a major effect on glucose metabolism should be avoided.<\/jats:p>","DOI":"10.1111\/j.1365-2893.2010.01417.x","type":"journal-article","created":{"date-parts":[[2011,1,11]],"date-time":"2011-01-11T08:48:50Z","timestamp":1294735730000},"source":"Crossref","is-referenced-by-count":34,"title":["Impact of HAART exposure and associated lipodystrophy on advanced liver fibrosis in HIV\/HCV\u2010coinfected patients"],"prefix":"10.1111","volume":"18","author":[{"given":"M.\u2010A.","family":"Loko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bani\u2010Sadr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Winnock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Lacombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Carrieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Neau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Morlat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Serfaty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Dabis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Salmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the ANRS CO 13 HEPAVIH Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,1,11]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200311070-00002"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1086\/367643"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1086\/514987"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1086\/527565"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3282f10de9"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510300409"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.07.006"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000210606.63138.f5"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31818ce821"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2009.00702.x"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.7.1035"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200411050-00008"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2009.01261.x"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003454"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3282f3553b"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7753(01)72168-9"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2008.00651.x"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.11.018"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1086\/509580"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1086\/510682"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2007.11.020"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2008.02.008"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1086\/505495"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1086\/589294"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32832b4377"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1086\/498312"},{"key":"e_1_2_8_28_2","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1177\/135965350601100701","article-title":"Antiretroviral therapy based on protease inhibitors as a protective factor against liver fibrosis progression in patients with chronic hepatitis C","volume":"11","author":"Macias J","year":"2006","journal-title":"Antivir Ther"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20074"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000174649.51084.46"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31819a2429"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000221683.44940.62"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1612"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2009.01238.x"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32805e8742"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2009.179085"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2009.184473"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2008.01813.x"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31818651e6"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e318189a780"},{"key":"e_1_2_8_41_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-2013"},{"key":"e_1_2_8_42_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2009.185074"},{"key":"e_1_2_8_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2009.01229.x"}],"container-title":["Journal of Viral Hepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2893.2010.01417.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2893.2010.01417.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2893.2010.01417.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/j.1365-2893.2010.01417.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2893.2010.01417.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T14:16:40Z","timestamp":1693837000000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2893.2010.01417.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,11]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["10.1111\/j.1365-2893.2010.01417.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2893.2010.01417.x","archive":["Portico"],"relation":{},"ISSN":["1352-0504","1365-2893"],"issn-type":[{"value":"1352-0504","type":"print"},{"value":"1365-2893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,11]]}}}